You are here

Boston Therapeutics

Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes

Reuters

Thu, 10/9/14 - 10:54 am

Boston Therapeutics

type 2 diabetes

Boston Therapeutics initiates Phase IIb study of Sugardown

The Fly on the Wall

Thu, 05/29/14 - 08:54 am

Boston Therapeutics

Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.

The Fly on the Wall

Tue, 03/4/14 - 09:18 am

Boston Therapeutics

The Future of Diabetes Control: Treat the Cause, Not the Symptom

Wall St Cheat Sheet

Thu, 12/5/13 - 10:04 am

Lexicon Pharmaceuticals

Boston Therapeutics